Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Evolution of DDB1-binding WD40 (DWD) in the viridiplantae.

Tevatia R, Oyler GA.

PLoS One. 2018 Jan 2;13(1):e0190282. doi: 10.1371/journal.pone.0190282. eCollection 2018.

2.

Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication.

Tsai YC, Kotiya A, Kiris E, Yang M, Bavari S, Tessarollo L, Oyler GA, Weissman AM.

Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5158-E5166. doi: 10.1073/pnas.1621076114. Epub 2017 Jun 5.

3.

Mimicking lichens: incorporation of yeast strains together with sucrose-secreting cyanobacteria improves survival, growth, ROS removal, and lipid production in a stable mutualistic co-culture production platform.

Li T, Li CT, Butler K, Hays SG, Guarnieri MT, Oyler GA, Betenbaugh MJ.

Biotechnol Biofuels. 2017 Mar 21;10:55. doi: 10.1186/s13068-017-0736-x. eCollection 2017.

4.

Pac-Man for biotechnology: co-opting degrons for targeted protein degradation to control and alter cell function.

Yu G, Rosenberg JN, Betenbaugh MJ, Oyler GA.

Curr Opin Biotechnol. 2015 Dec;36:199-204. doi: 10.1016/j.copbio.2015.08.023. Epub 2015 Oct 1. Review.

PMID:
26435348
5.

Comparison of biomass and lipid production under ambient carbon dioxide vigorous aeration and 3% carbon dioxide condition among the lead candidate Chlorella strains screened by various photobioreactor scales.

Kobayashi N, Barnes A, Jensen T, Noel E, Andlay G, Rosenberg JN, Betenbaugh MJ, Guarnieri MT, Oyler GA.

Bioresour Technol. 2015 Dec;198:246-55. doi: 10.1016/j.biortech.2015.08.124. Epub 2015 Sep 1.

PMID:
26398668
6.

Bioprospecting of microalgae for integrated biomass production and phytoremediation of unsterilized wastewater and anaerobic digestion centrate.

Bohutskyi P, Liu K, Nasr LK, Byers N, Rosenberg JN, Oyler GA, Betenbaugh MJ, Bouwer EJ.

Appl Microbiol Biotechnol. 2015 Jul;99(14):6139-54. doi: 10.1007/s00253-015-6603-4. Epub 2015 May 7.

PMID:
25947241
7.

Chlorovirus Skp1-binding ankyrin repeat protein interplay and mimicry of cellular ubiquitin ligase machinery.

Noel EA, Kang M, Adamec J, Van Etten JL, Oyler GA.

J Virol. 2014 Dec;88(23):13798-810. doi: 10.1128/JVI.02109-14. Epub 2014 Sep 24.

8.
9.

The effect of iron on growth, lipid accumulation, and gene expression profile of the freshwater microalga Chlorella sorokiniana.

Wan M, Jin X, Xia J, Rosenberg JN, Yu G, Nie Z, Oyler GA, Betenbaugh MJ.

Appl Microbiol Biotechnol. 2014 Nov;98(22):9473-81. doi: 10.1007/s00253-014-6088-6. Epub 2014 Sep 25.

PMID:
25248441
10.

Algal chloroplast produced camelid VH H antitoxins are capable of neutralizing botulinum neurotoxin.

Barrera DJ, Rosenberg JN, Chiu JG, Chang YN, Debatis M, Ngoi SM, Chang JT, Shoemaker CB, Oyler GA, Mayfield SP.

Plant Biotechnol J. 2015 Jan;13(1):117-24. doi: 10.1111/pbi.12244. Epub 2014 Sep 17.

11.

Comparative analyses of three Chlorella species in response to light and sugar reveal distinctive lipid accumulation patterns in the Microalga C. sorokiniana.

Rosenberg JN, Kobayashi N, Barnes A, Noel EA, Betenbaugh MJ, Oyler GA.

PLoS One. 2014 Apr 3;9(4):e92460. doi: 10.1371/journal.pone.0092460. eCollection 2014.

12.

Characterization of three Chlorella sorokiniana strains in anaerobic digested effluent from cattle manure.

Kobayashi N, Noel EA, Barnes A, Watson A, Rosenberg JN, Erickson G, Oyler GA.

Bioresour Technol. 2013 Dec;150:377-86. doi: 10.1016/j.biortech.2013.10.032. Epub 2013 Oct 18.

13.

Generation of a phage-display library of single-domain camelid VH H antibodies directed against Chlamydomonas reinhardtii antigens, and characterization of VH Hs binding cell-surface antigens.

Jiang W, Rosenberg JN, Wauchope AD, Tremblay JM, Shoemaker CB, Weeks DP, Oyler GA.

Plant J. 2013 Nov;76(4):709-17. doi: 10.1111/tpj.12316. Epub 2013 Oct 17.

14.

Rapid detection and quantification of triacylglycerol by HPLC-ELSD in Chlamydomonas reinhardtii and Chlorella strains.

Kobayashi N, Noel EA, Barnes A, Rosenberg J, DiRusso C, Black P, Oyler GA.

Lipids. 2013 Oct;48(10):1035-49. doi: 10.1007/s11745-013-3828-9. Epub 2013 Aug 23.

15.

Expanding the spectral palette of fluorescent proteins for the green microalga Chlamydomonas reinhardtii.

Rasala BA, Barrera DJ, Ng J, Plucinak TM, Rosenberg JN, Weeks DP, Oyler GA, Peterson TC, Haerizadeh F, Mayfield SP.

Plant J. 2013 May;74(4):545-56. doi: 10.1111/tpj.12165. Epub 2013 Apr 8.

16.

Persistence of Botulinum neurotoxin inactivation of nerve function.

Shoemaker CB, Oyler GA.

Curr Top Microbiol Immunol. 2013;364:179-96. doi: 10.1007/978-3-642-33570-9_9.

17.

Achieving high throughput sequencing of a cDNA library utilizing an alternative protocol for the bench top next-generation sequencing system.

Wan M, Faruq J, Rosenberg JN, Xia J, Oyler GA, Betenbaugh MJ.

J Microbiol Methods. 2013 Feb 15;92(2):122-6. doi: 10.1016/j.mimet.2012.10.010. Epub 2012 Nov 2.

PMID:
23127394
18.

Tyrosine phosphorylation of botulinum neurotoxin protease domains.

Toth S, Brueggmann EE, Oyler GA, Smith LA, Hines HB, Ahmed SA.

Front Pharmacol. 2012 Jun 4;3:102. doi: 10.3389/fphar.2012.00102. eCollection 2012.

19.

Physiological evaluation of a new Chlorella sorokiniana isolate for its biomass production and lipid accumulation in photoautotrophic and heterotrophic cultures.

Wan MX, Wang RM, Xia JL, Rosenberg JN, Nie ZY, Kobayashi N, Oyler GA, Betenbaugh MJ.

Biotechnol Bioeng. 2012 Aug;109(8):1958-64. doi: 10.1002/bit.24477. Epub 2012 Mar 2.

PMID:
22354808
20.

Retargeting Clostridium difficile Toxin B to Neuronal Cells as a Potential Vehicle for Cytosolic Delivery of Therapeutic Biomolecules to Treat Botulism.

Krautz-Peterson G, Zhang Y, Chen K, Oyler GA, Feng H, Shoemaker CB.

J Toxicol. 2012;2012:760142. doi: 10.1155/2012/760142. Epub 2011 Sep 20.

21.

The effect of mixotrophy on microalgal growth, lipid content, and expression levels of three pathway genes in Chlorella sorokiniana.

Wan M, Liu P, Xia J, Rosenberg JN, Oyler GA, Betenbaugh MJ, Nie Z, Qiu G.

Appl Microbiol Biotechnol. 2011 Aug;91(3):835-44. doi: 10.1007/s00253-011-3399-8. Epub 2011 Jun 23.

PMID:
21698379
22.

Accelerated neuronal cell recovery from Botulinum neurotoxin intoxication by targeted ubiquitination.

Kuo CL, Oyler GA, Shoemaker CB.

PLoS One. 2011;6(5):e20352. doi: 10.1371/journal.pone.0020352. Epub 2011 May 24.

23.

Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system.

Tsai YC, Maditz R, Kuo CL, Fishman PS, Shoemaker CB, Oyler GA, Weissman AM.

Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16554-9. doi: 10.1073/pnas.1008302107. Epub 2010 Sep 7.

24.

Green algae as a platform to express therapeutic proteins.

Lu Y, Oyler GA.

Discov Med. 2009 Jun;8(40):28-30. Review.

25.

An improved in vitro and in vivo Sindbis virus expression system through host and virus engineering.

Nivitchanyong T, Tsai YC, Betenbaugh MJ, Oyler GA.

Virus Res. 2009 Apr;141(1):1-12. doi: 10.1016/j.virusres.2008.12.019. Epub 2009 Feb 5.

26.

E2F-1 overexpression increases viable cell density in batch cultures of Chinese hamster ovary cells.

Majors BS, Arden N, Oyler GA, Chiang GG, Pederson NE, Betenbaugh MJ.

J Biotechnol. 2008 Nov 25;138(3-4):103-6. doi: 10.1016/j.jbiotec.2008.08.003. Epub 2008 Aug 20.

PMID:
18778741
27.

A green light for engineered algae: redirecting metabolism to fuel a biotechnology revolution.

Rosenberg JN, Oyler GA, Wilkinson L, Betenbaugh MJ.

Curr Opin Biotechnol. 2008 Oct;19(5):430-6. doi: 10.1016/j.copbio.2008.07.008. Epub 2008 Sep 6. Review.

PMID:
18725295
28.

The C-terminal transmembrane domain of Bcl-xL mediates changes in mitochondrial morphology.

Zheng JY, Tsai YC, Kadimcherla P, Zhang R, Shi J, Oyler GA, Boustany NN.

Biophys J. 2008 Jan 1;94(1):286-97. Epub 2007 Aug 31.

29.

Combining caspase and mitochondrial dysfunction inhibitors of apoptosis to limit cell death in mammalian cell cultures.

Sauerwald TM, Figueroa B Jr, Hardwick JM, Oyler GA, Betenbaugh MJ.

Biotechnol Bioeng. 2006 Jun 5;94(2):362-72.

PMID:
16598795
30.

BCL-xL-dependent light scattering by apoptotic cells.

Boustany NN, Tsai YC, Pfister B, Joiner WM, Oyler GA, Thakor NV.

Biophys J. 2004 Dec;87(6):4163-71. Epub 2004 Sep 17.

31.

Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions.

Figueroa B Jr, Chen S, Oyler GA, Hardwick JM, Betenbaugh MJ.

Biotechnol Bioeng. 2004 Mar 20;85(6):589-600.

PMID:
14966800
32.

A comparison of the properties of a Bcl-xL variant to the wild-type anti-apoptosis inhibitor in mammalian cell cultures.

Figueroa B Jr, Sauerwald TM, Oyler GA, Hardwick JM, Betenbaugh MJ.

Metab Eng. 2003 Oct;5(4):230-45.

PMID:
14642351
33.

Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25.

Apland JP, Adler M, Oyler GA.

J Protein Chem. 2003 Feb;22(2):147-53.

PMID:
12760419
34.

Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function.

Tsai YC, Fishman PS, Thakor NV, Oyler GA.

J Biol Chem. 2003 Jun 13;278(24):22044-55. Epub 2003 Apr 3.

35.

Study of caspase inhibitors for limiting death in mammalian cell culture.

Sauerwald TM, Oyler GA, Betenbaugh MJ.

Biotechnol Bioeng. 2003 Feb 5;81(3):329-40.

PMID:
12474256
36.

Significance of the parkin gene and protein in understanding Parkinson's disease.

Fishman PS, Oyler GA.

Curr Neurol Neurosci Rep. 2002 Jul;2(4):296-302. Review.

PMID:
12044248
37.

Neuromuscular transmission and muscle contractility in SNAP-25-deficient coloboma mice.

Adler M, Sheridan RE, Deshpande SS, Oyler GA.

Neurotoxicology. 2001 Dec;22(6):775-86.

PMID:
11829411
38.

Inhibiting apoptosis in mammalian cell culture using the caspase inhibitor XIAP and deletion mutants.

Sauerwald TM, Betenbaugh MJ, Oyler GA.

Biotechnol Bioeng. 2002 Mar 20;77(6):704-16.

PMID:
11807766
39.

Inhibition of virus-induced neuronal apoptosis by Bax.

Lewis J, Oyler GA, Ueno K, Fannjiang YR, Chau BN, Vornov J, Korsmeyer SJ, Zou S, Hardwick JM.

Nat Med. 1999 Jul;5(7):832-5.

PMID:
10395331
40.

AIDS-related MR hyperintensity of the basal ganglia.

Meltzer CC, Wells SW, Becher MW, Flanigan KM, Oyler GA, Lee RR.

AJNR Am J Neuroradiol. 1998 Jan;19(1):83-9.

41.

Tau phosphorylation in brain slices: pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase.

Garver TD, Oyler GA, Harris KA, Polavarapu R, Damuni Z, Lehman RA, Billingsley ML.

Mol Pharmacol. 1995 Apr;47(4):745-56.

PMID:
7723735
42.

Okadaic acid induces hyperphosphorylated forms of tau protein in human brain slices.

Harris KA, Oyler GA, Doolittle GM, Vincent I, Lehman RA, Kincaid RL, Billingsley ML.

Ann Neurol. 1993 Jan;33(1):77-87.

PMID:
8494335
43.
44.

Distribution and expression of SNAP-25 immunoreactivity in rat brain, rat PC-12 cells and human SMS-KCNR neuroblastoma cells.

Oyler GA, Polli JW, Higgins GA, Wilson MC, Billingsley ML.

Brain Res Dev Brain Res. 1992 Feb 21;65(2):133-46.

PMID:
1572061
45.

Developmental expression of the 25-kDa synaptosomal-associated protein (SNAP-25) in rat brain.

Oyler GA, Polli JW, Wilson MC, Billingsley ML.

Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5247-51.

46.

Use of avidin-biotin subtractive hybridization to characterize mRNA common to neurons destroyed by the selective neurotoxicant trimethyltin.

Krady JK, Oyler GA, Balaban CD, Billingsley ML.

Brain Res Mol Brain Res. 1990 May;7(4):287-97.

PMID:
2163004
47.

Altered levels of amyloid protein precursor transcripts in the basal forebrain of behaviorally impaired aged rats.

Higgins GA, Oyler GA, Neve RL, Chen KS, Gage FH.

Proc Natl Acad Sci U S A. 1990 Apr;87(8):3032-6.

48.

The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations.

Oyler GA, Higgins GA, Hart RA, Battenberg E, Billingsley M, Bloom FE, Wilson MC.

J Cell Biol. 1989 Dec;109(6 Pt 1):3039-52.

49.

Localization of nerve growth factor receptor messenger RNA and protein in the adult rat brain.

Koh S, Oyler GA, Higgins GA.

Exp Neurol. 1989 Dec;106(3):209-21.

PMID:
2556291

Supplemental Content

Loading ...
Support Center